These findings suggest that nanovesicles, by delivering PEBP1 mRNA, effectively activate the NRF2/GPX4 axis, reducing intracellular oxidative stress and iron ion toxicity and potentially attenuating VSMC damage associated with AAA. Here, GPX4 is linked to triple-A syndrome.